[1] Rendon A, Schäkel K. Psoriasis pathogenesis and treatment[J]. Int J Mol Sci, 2019, 20(6):1475. DOI: 10.3390/ijms20061475.
[2] 陆子轩,吴建华.胞外囊泡在银屑病中的研究进展[J].中国麻风皮肤病杂志,2023,39(3):218-222.DOI:10.12144/zgmfskin202303218.
[3] Liu Y, Dong Y, Wu X, et al. Identification of immune microenvironment changes and the expression of immune-related genes in liver cirrhosis[J]. Front Immunol, 2022, 13:918445. DOI: 10.3389/fimmu.2022.918445.
[4] D'Amico G, Morabito A, D'Amico M, et al. Clinical states of cirrhosis and competing risks[J]. J Hepatol, 2018, 68(3):563-576. DOI: 10.1016/j.jhep.2017.10.020.
[5] Diotallevi F, Di Vincenzo M, Martina E, et al. Mesenchymal stem cells and psoriasis: systematic review[J]. Int J Mol Sci, 2022, 23(23):15080. DOI: 10.3390/ijms232315080.
[6] Liang N, Chang W, Peng A, et al. Dermal mesenchymal stem cells from psoriatic lesions stimulate HaCaT cell proliferation, differentiation, and migration via activating the PI3K/AKT signaling pathway[J]. Dermatology, 2022, 238(2):283-291. DOI: 10.1159/000515767.
[7] 中华医学会医学工程学分会干细胞工程专业学组,Medical Engineering Society of Chinese Medical Association.干细胞移植规范化治疗肝硬化失代偿的专家共识(2021)[J].临床肝胆病杂志,2021,37(7):1540-1544. DOI:10.3969/j.issn.1001-5256.2021.07.012.
[8] Chang W, Liang N, Cao Y, et al. The effects of human dermal-derived mesenchymal stem cells on the keratinocyte proliferation and apoptosis in psoriasis[J]. Exp Dermatol, 2021, 30(7):943-950. DOI: 10.1111/exd.14353.
[9] Orciani M, Campanati A, Salvolini E, et al. The mesenchymal stem cell profile in psoriasis[J]. Br J Dermatol, 2011, 165(3):585-592. DOI: 10.1111/j.1365-2133.2011.10438.x.
[10] Campanati A, Orciani M, Consales V, et al. Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1-Th17/Th2 imbalance of psoriasis[J]. Arch Dermatol Res, 2014, 306(10):915-920. DOI: 10.1007/s00403-014-1493-3.
[11] Liu R, Yang Y, Yan X, et al. Abnormalities in cytokine secretion from mesenchymal stem cells in psoriatic skin lesions[J]. Eur J Dermatol, 2013, 23(5):600-607. DOI: 10.1684/ejd.2013.2149.
[12] Wang Y, Liang Y, Li J, et al. Expression and functional regulation of gap junction protein connexin 43 in dermal mesenchymal stem cells from psoriasis patients[J]. Acta Histochem, 2020, 122(4):151550. DOI: 10.1016/j.acthis.2020.151550.
[13] Li J, Xing J, Lu F, et al. Psoriatic dermal-derived mesenchymal stem cells reduce keratinocyte junctions, and increase glycolysis[J]. Acta Derm Venereol, 2020, 100(8):adv00122. DOI: 10.2340/00015555-3480.
[14] Shin TH, Kim HS, Choi SW, et al. Mesenchymal stem cell therapy for inflammatory skin diseases: clinical potential and mode of action[J]. Int J Mol Sci, 2017, 18(2):244. DOI: 10.3390/ijms18020244.
[15] Glennie S, Soeiro I, Dyson PJ, et al. Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells[J]. Blood, 2005, 105(7):2821-2827. DOI: 10.1182/blood-2004-09-3696.
[16] English K, Ryan JM, Tobin L, et al. Cell contact, prostaglandin E(2) and transforming growth factor beta 1 play non-redundant roles in human mesenchymal stem cell induction of CD4+CD25(high) forkhead box P3+ regulatory T cells[J]. Clin Exp Immunol, 2009, 156(1):149-160. DOI: 10.1111/j.1365-2249.2009.03874.x.
[17] Di Nicola M, Carlo-Stella C, Magni M, et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli[J]. Blood, 2002, 99(10):3838-3843. DOI: 10.1182/blood.v99.10.3838.
[18] Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses[J]. Blood, 2005, 105(4):1815-1822. DOI: 10.1182/blood-2004-04-1559.
[19] Paganelli A, Tarentini E, Benassi L, et al. Mesenchymal stem cells for the treatment of psoriasis: a comprehensive review[J]. Clin Exp Dermatol, 2020, 45(7):824-830. DOI: 10.1111/ced.14269.
[20] Chen Y, Yu Q, Hu Y, et al. Current research and use of mesenchymal stem cells in the therapy of autoimmune diseases[J]. Curr Stem Cell Res Ther, 2019, 14(7):579-582. DOI: 10.2174/1574888X14666190429141421.
[21] Orciani M, Campanati A, Caffarini M, et al. T helper (Th)1, Th17 and Th2 imbalance in mesenchymal stem cells of adult patients with atopic dermatitis: at the origin of the problem[J]. Br J Dermatol, 2017, 176(6):1569-1576. DOI: 10.1111/bjd.15078.
|